Spontaneous bacterial peritonitis primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
* Prevention of [[peritonitis]] in cases of [[ascites]].
* Prevention of [[peritonitis]] in cases of [[ascites]].
* Intravenous [[ceftriaxone]] for 7 days or twice-daily norfloxacin for 7 days should be given to prevent [[bacterial infections]] in patients with [[cirrhosis]] and [[gastrointestinal hemorrhage]]. <ref name="pmid12076458">{{cite journal |author=Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L |title=Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding |journal=Cochrane database of systematic reviews (Online) |volume= |issue=2 |pages=CD002907 |year=2002 |pmid=12076458 |doi=}}</ref>  
* Intravenous [[ceftriaxone]] for 7 days or twice-daily norfloxacin for 7 days should be given to prevent [[bacterial infections]] in patients with [[cirrhosis]] and [[gastrointestinal hemorrhage]]. <ref name="pmid12076458">{{cite journal |author=Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L |title=Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding |journal=Cochrane database of systematic reviews (Online) |volume= |issue=2 |pages=CD002907 |year=2002 |pmid=12076458 |doi=}}</ref>  
* Intermittent dosing of antibiotics to prevent bacterial infections may be inferior to daily dosing (due to the development of bacterial resistance) and thus daily dosing should preferentially be used. <ref>http://guideline.gov/content.aspx?id=14887&search=ascitis</ref>
* Intermittent dosing of antibiotics to prevent bacterial infections may be inferior to daily dosing (due to the development of bacterial resistance) and thus daily dosing should preferentially be used. <ref name="urlNational Guideline Clearinghouse | Management of adult patients with ascites due to cirrhosis: an update.">{{cite web |url=http://guideline.gov/content.aspx?id=14887&search=ascitis |title=National Guideline Clearinghouse &#124; Management of adult patients with ascites due to cirrhosis: an update. |format= |work= |accessdate=}}</ref>


==References==
==References==

Revision as of 15:47, 2 August 2012

Peritonitis main page

Spontaneous bacterial peritonitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Spontaneous bacterial peritonitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Spontaneous bacterial peritonitis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Spontaneous bacterial peritonitis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Spontaneous bacterial peritonitis primary prevention

CDC on Spontaneous bacterial peritonitis primary prevention

Spontaneous bacterial peritonitis primary prevention in the news

Blogs on Spontaneous bacterial peritonitis primary prevention

Directions to Hospitals Treating Spontaneous bacterial peritonitis

Risk calculators and risk factors for Spontaneous bacterial peritonitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Primary prevention

References

  1. Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L (2002). "Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding". Cochrane database of systematic reviews (Online) (2): CD002907. PMID 12076458.
  2. "National Guideline Clearinghouse | Management of adult patients with ascites due to cirrhosis: an update".

Template:WH Template:WS